InvestmentJul 7, 2026, 04:17 PM
Lifeward Secures $5.6M Initial Financing, up to $11.2M Total
AI Summary
Lifeward Ltd. announced it secured approximately $5.6 million in initial financing through a securities purchase agreement with institutional and accredited investors. This funding, consisting of senior secured convertible notes and warrants, is part of a strategic financing framework. Investors have committed an additional $5.6 million upon achieving specific commercial milestones, such as a 150% increase in ReWalk unit sales or the company's shares trading above $13.80 for ten consecutive days. This capital aims to accelerate the commercialization of its restorative healthcare platform and advance its product portfolio.
Key Highlights
- Initial financing closed for approximately $5.6 million.
- Financing consists of senior secured convertible notes and warrants.
- Investors committed an additional $5.6 million upon commercial milestones.
- Milestones include a 150% increase in ReWalk unit sales.
- Alternatively, LFWD shares trading above $13.80 for ten consecutive days.
- This financing expands on a strategic capital framework with Oramed Pharmaceuticals.
- The Oramed framework provides access to up to $47 million, with $10 million funded to date.
Price Impact
More from LFWD